Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor At the completion of 7 years of follow-up after abdominal sacrocolpopexy performed as part of a randomized trial (Colpopexy and Urinary Reduction Efforts [CARE]),1 Dr Nygaard and colleagues2 concluded that abdominal sacrocolpopexy was less effective than desired as a standard criterion procedure for pelvic organ prolapse (POP) because of high rates of anatomic failure (22%-27%), symptomatic failure (24%-29%), and mesh erosion through the vaginal wall (10.5%). However, a Cochrane review published in 2013 concluded that for upper vaginal prolapse, abdominal sacrocolpopexy has superior outcomes compared with a variety of vaginal procedures, including sacrospinous colpopexy, uterosacral colpopexy, and transvaginal mesh.3 The CARE trial was designed to investigate the efficacy of the addition of a colposuspension to protect against postoperative urinary incontinence after sacrocolpopexy, but not to assess the long-term outcomes of sacrocolpopexy.
Fujita T. Surgery for Pelvic Organ Prolapse. JAMA. 2013;310(10):1073. doi:10.1001/jama.2013.238041